| Year |
Citation |
Score |
| 2021 |
Fischer T, Riedl R. Paracelsus' legacy in the faunal realm: Drugs deriving from animal toxins. Drug Discovery Today. PMID 34678490 DOI: 10.1016/j.drudis.2021.10.003 |
0.596 |
|
| 2021 |
Zizzari AT, Pliatsika D, Gall FM, Fischer T, Riedl R. New perspectives in oral peptide delivery. Drug Discovery Today. PMID 33497830 DOI: 10.1016/j.drudis.2021.01.020 |
0.584 |
|
| 2020 |
Fischer T, Riedl R. Challenges with matrix metalloproteinase inhibition and future drug discovery avenues. Expert Opinion On Drug Discovery. 1-14. PMID 32921161 DOI: 10.1080/17460441.2020.1819235 |
0.707 |
|
| 2019 |
Fischer T, Riedl R. Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation. Molecules (Basel, Switzerland). 24. PMID 31216704 DOI: 10.3390/Molecules24122265 |
0.711 |
|
| 2019 |
Fischer T, Gazzola S, Riedl R. Approaching Target Selectivity by De Novo Drug Design. Expert Opinion On Drug Discovery. 1-13. PMID 31179763 DOI: 10.1080/17460441.2019.1615435 |
0.679 |
|
| 2019 |
Fischer T, Koulas SM, Tsagkarakou AS, Kyriakis E, Stravodimos GA, Skamnaki VT, Liggri PGV, Zographos SE, Riedl R, Leonidas DD. High Consistency of Structure-Based Design and X-Ray Crystallography: Design, Synthesis, Kinetic Evaluation and Crystallographic Binding Mode Determination of Biphenyl--acyl-β-d-Glucopyranosylamines as Glycogen Phosphorylase Inhibitors. Molecules (Basel, Switzerland). 24. PMID 30987252 DOI: 10.3390/Molecules24071322 |
0.656 |
|
| 2019 |
Fischer T, Senn N, Riedl R. Design and Structural Evolution of Matrix Metalloproteinase Inhibitors. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 30720221 DOI: 10.1002/Chem.201805361 |
0.744 |
|
| 2019 |
Fischer T, Senn N, Riedl R. Frontispiece: Design and Structural Evolution of Matrix Metalloproteinase Inhibitors Chemistry – a European Journal. 25. DOI: 10.1002/Chem.201983461 |
0.709 |
|
| 2017 |
Fischer T, Riedl R. Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 Inhibitor. Molecules (Basel, Switzerland). 22. PMID 32961647 DOI: 10.3390/Molecules22091548 |
0.708 |
|
| 2017 |
Fischer T, Riedl R. Targeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase Inhibitor. Chemistryopen. 6: 192-195. PMID 28413749 DOI: 10.1002/Open.201600158 |
0.733 |
|
| 2017 |
Fischer T, Riedl R. Targeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase Inhibitor. Chemistryopen. 6: 167. PMID 28413746 DOI: 10.1002/open.201700042 |
0.725 |
|
| 2017 |
Fischer T, Riedl R. Cover profile : targeted fluoro positioning for the discovery of a potent and highly selective matrix metalloproteinase inhibitor Chemistryopen. 6: 167. DOI: 10.21256/Zhaw-1688 |
0.73 |
|
| 2017 |
Fischer T, Riedl R. Cover Picture: Targeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase Inhibitor (ChemistryOpen 2/2017) Chemistryopen. 6: 165-165. DOI: 10.1002/Open.201700043 |
0.73 |
|
| 2016 |
Fischer T, Riedl R. Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies. International Journal of Molecular Sciences. 17. PMID 26938528 DOI: 10.3390/Ijms17030314 |
0.698 |
|
| 2013 |
Fischer T, Riedl R. Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors. Chemmedchem. 8: 1457-61, 1572. PMID 23894097 DOI: 10.1002/Cmdc.201300278 |
0.672 |
|
| 2013 |
Fischer T, Riedl R. Back Cover: Strategic Targeting of Multiple Water‐Mediated Interactions: A Concise and Rational Structure‐Based Design Approach to Potent and Selective MMP‐13 Inhibitors (ChemMedChem 9/2013) Chemmedchem. 8: 1572-1572. DOI: 10.1002/Cmdc.201390039 |
0.685 |
|
| Show low-probability matches. |